Risk Factors for Postprocedural Arterial Ischemic Stroke in Children With Cardiac Disease.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 20 8 2020
medline: 31 10 2020
entrez: 20 8 2020
Statut: ppublish

Résumé

Cardiac pathologies are the second most frequent risk factor (RF) in children with arterial ischemic stroke (AIS). This study aimed to analyze RFs for AIS in children with cardiac disease and cardiac intervention. Data were drawn from the Swiss Neuropediatric Stroke Registry. Patients with cardiac disease and postprocedural AIS registered from 2000 until 2015 were analyzed for the cause of cardiac disease and for potential RFs. Forty-seven out of 78 children with cardiac disease had a cardiac intervention. Of these, 36 presented a postprocedural AIS. Median time from cardiac intervention to symptom onset was 4 days (interquartile range, 2-8.5); time to diagnosis of AIS was 2 days (interquartile range, 0-5.8). Main RFs for postprocedural AIS were hypotension, prosthetic cardiac material, right-to-left shunt, arrhythmias, low cardiac output, and infections. In children with postprocedural AIS, time to diagnosis was delayed. Most patients presented multiple potentially modifiable RFs as hemodynamic alterations and infections.

Sections du résumé

BACKGROUND AND PURPOSE
Cardiac pathologies are the second most frequent risk factor (RF) in children with arterial ischemic stroke (AIS). This study aimed to analyze RFs for AIS in children with cardiac disease and cardiac intervention.
METHODS
Data were drawn from the Swiss Neuropediatric Stroke Registry. Patients with cardiac disease and postprocedural AIS registered from 2000 until 2015 were analyzed for the cause of cardiac disease and for potential RFs.
RESULTS
Forty-seven out of 78 children with cardiac disease had a cardiac intervention. Of these, 36 presented a postprocedural AIS. Median time from cardiac intervention to symptom onset was 4 days (interquartile range, 2-8.5); time to diagnosis of AIS was 2 days (interquartile range, 0-5.8). Main RFs for postprocedural AIS were hypotension, prosthetic cardiac material, right-to-left shunt, arrhythmias, low cardiac output, and infections.
CONCLUSIONS
In children with postprocedural AIS, time to diagnosis was delayed. Most patients presented multiple potentially modifiable RFs as hemodynamic alterations and infections.

Identifiants

pubmed: 32811375
doi: 10.1161/STROKEAHA.120.029447
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e242-e245

Auteurs

Bettina C Henzi (BC)

Division of Child Neurology, Department of Pediatrics, University Children's Hospital Bern, University of Bern, Switzerland (B.C.H., M.R., M.S.).
Department of Pediatric Neurology and Developmental Medicine, University of Basel, Children's Hospital Basel, Switzerland (B.C.H., A.N.D.).

Barbara Brotschi (B)

Department of Pediatric and Neonatal Intensive Care, University Children's Hospital Zurich, Switzerland (B.B.).

Christian Balmer (C)

Department of Pediatric Cardiology, University Children's Hospital Zurich, Switzerland (C.B.).

Bert Hennig (B)

Division of Pediatric Intensive Care, University Children's Hospital Bern, University of Bern, Switzerland (B.H.).

Peter Rimensberger (P)

Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital of Geneva, Switzerland (P.R.).

Marie-Hélène Perez (MH)

Pediatric Intensive Care Unit, Department of Pediatrics, University Hospital of Lausanne, Switzerland (M.-H.P.).

Jean-Pierre Pfammatter (JP)

Center for Congenital Heart Disease, Departments of Cardiology and Cardiac Surgery, University Hospital of Bern, Switzerland (J.-P.P.).

Maurice Beghetti (M)

Pediatric Cardiology Unit, University Children's Hospital HUG, Pulmonary Hypertension Program HUG, Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatrique (CURCCCP), University of Geneva, Switzerland (M.B.).

Nicole Sekarski (N)

Pediatric Cardiology Unit, Department of Pediatrics, Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pediatrique (CURCCCP), Lausanne University Hospital, Switzerland (N.S.).

Alexandre N Datta (AN)

Department of Pediatric Neurology and Developmental Medicine, University of Basel, Children's Hospital Basel, Switzerland (B.C.H., A.N.D.).

Joel Fluss (J)

Pediatric Neurology Unit, Geneva Children's Hospital, Switzerland (J.F.).

Nicole Faignart (N)

Pediatric Neurology, Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital, Switzerland (N.F.).

Annette Hackenberg (A)

Department of Pediatric Neurology, University Children's Hospital Zurich, Switzerland (A.H.).

Mária Regényi (M)

Division of Child Neurology, Department of Pediatrics, University Children's Hospital Bern, University of Bern, Switzerland (B.C.H., M.R., M.S.).

Maja Steinlin (M)

Division of Child Neurology, Department of Pediatrics, University Children's Hospital Bern, University of Bern, Switzerland (B.C.H., M.R., M.S.).

Maja I Hug (MI)

Department of Neonatology, University of Basel Children's Hospital (UKBB), Switzerland (M.I.H.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH